Scientific context only. Not medical advice, not a recommendation to use.
At a glance
Oxytocin is an endogenous nonapeptide hormone of the posterior pituitary. In synthetic form (Pitocin, Syntocinon) it has been approved for decades to induce and augment labour and to control postpartum uterine bleeding. Strictly separate from this is intranasal use to influence social behaviour, trust, anxiety or autism symptoms: this use is unapproved, purely experimental, and yields inconsistent and often negative results in controlled trials.
Researched for
Labour induction and augmentation (approved indication)Control of postpartum uterine bleeding (approved indication)Social cognition and autism spectrum symptoms (experimental, inconsistent evidence)Trust, bonding and anxiety/stress processing (experimental)
Official status
US: Prescription
In the US, injectable oxytocin (e.g. Pitocin) is FDA-approved as a prescription drug for labour induction/augmentation and control of postpartum bleeding. Intranasal use for social/behavioural purposes is not approved and is considered experimental.
Oxytocin is synthesised in the hypothalamus and released via the posterior pituitary. Peripherally it binds the oxytocin receptor, a G-protein-coupled receptor, and through the phospholipase-C cascade and calcium release triggers contraction of uterine smooth muscle and milk ejection — the pharmacological basis of the obstetric approval. Centrally, oxytocin acts as a neuromodulator and has been linked to social bonding, trust and modulation of stress and anxiety circuits. Its central effects in humans are mechanistically incompletely understood, particularly because it is unclear to what extent peripherally or intranasally administered oxytocin crosses the blood-brain barrier.
02
Evidence at a glance
Reading note. The distribution shows on which evidence tier each observation sits. Strong colours mark stronger evidence — weaker tiers are deliberately visible, not hidden.
3 observations · 2 tiers
Human RCT
2
Human trial
1
03
What the studies show
Human RCT
Mensch
Alfirevic Z., Kelly AJ., Dowswell T. 2009
Induction and augmentation of uterine contractions and reduction of postpartum bleeding in obstetric use
What does NOT follow: This is the only broadly approved use and concerns exclusively controlled clinical obstetrics under medical supervision. It is not a statement about self-administration or about social/behavioural effects.
Human RCT
Mensch
Yamasue H. et al. 2020
No consistent benefit on core social symptoms of autism spectrum disorder in controlled trials
What does NOT follow: The evidence is inconsistent. Several randomised controlled trials found no difference between intranasal oxytocin and placebo on the primary endpoint; isolated secondary endpoints suggested effects but are unconfirmed. This use is unapproved and purely experimental.
Human trial
Mensch
Kosfeld M., Heinrichs M., Zak PJ., Fischbacher U., Fehr E. 2005
Increased trusting behaviour in an economic game experiment reported after intranasal administration
What does NOT follow: A single, widely cited laboratory finding in healthy participants in an artificial game setting. Subsequent replication attempts have been inconsistent; the effect is not considered robustly established and does not support any everyday application.
04
Where studies disagree
Open question
Does intranasal oxytocin reproducibly improve social cognition in humans?
POSITION A
Early isolated findings (e.g. on trust or emotion recognition) suggested intranasal oxytocin could improve social behaviour.
POSITION B
Larger, better-controlled randomised trials and replication attempts frequently failed to find the effect; central efficacy after intranasal administration is not established.
CURRENT STATE · The overall evidence is considered inconsistent. This is a contextualisation of the conflicting evidence, not a usage statement.
05
Pharmacokinetics
Theoretical concentration curve at a half-life of 0.05 h. Pure pharmacokinetic model — not a dosing recommendation.
Which routes of administration the available studies describe — neutral reporting, not a usage guide.
Intravenous
The only accepted route in approved obstetric use; exclusively clinical and medically supervised.
Intranasal
Predominantly investigated in experimental research on social behaviour. Not approved; the central availability of this route is scientifically debated.
06d
Safer use & risks
Risk notes for harm reduction — descriptive, not a usage or dosing guide.
⚠ Important — please read
This platform does NOT provide usage or dosing instructions. The points below describe risks and are meant to help avoid harm — they do not replace medical advice. Anyone who uses a substance should discuss it with a doctor.
This substance is approved (in at least one country) — use belongs in medical hands, within the approved indication and a physician-set dose.
Online numbers are not a benchmark
Amounts from TikTok, YouTube and forums are mostly imitation rather than data — and are often wrongly derived from animal studies (µg/kg). Not a reliable benchmark for humans.
Sterility & infection risk
Injection solutions prepared or stored non-sterile carry an infection and abscess risk. Contamination is common with grey-market product.
Unknown product quality
Research-/grey-market product is not quality-tested: identity, purity and actual content are often unknown, and counterfeits occur.
Mind interactions
Combinations with medications or pre-existing conditions can carry risks (see the Interactions section). Clarify with a doctor beforehand.
Warning signs — seek medical help
With persistent pain, redness/swelling at the injection site, fever, shortness of breath, racing heart, chest pain or allergic reactions, seek medical help immediately.
A doctor, not a forum
Concrete questions about use and amount belong in a conversation with a doctor — not in a comment thread.
07b
Interactions & combinations
Documented interactions and contraindications from studies, prescribing information and guidelines. Where no data exists, this is stated.
Reporting of risks, NOT a combination guide. The absence of an entry does not mean „safe to combine“ but „not sufficiently studied“.
No documented interactions recorded
We have not yet found robustly documented interactions for this peptide. This does NOT mean none exist — the data is limited.
10
Anecdotal observations
Weakest evidence tier — not supported by studies
Reading note. This section gathers popular claims from communities and forums. They are explicitly marked as weakest-tier evidence. Unblinded self-reports are particularly prone to placebo, recall and confirmation biases.
Why no amounts or protocols are listed here. We deliberately show only WHAT communities report — not in what amount or how it is used. Anecdotal "doses" or "biohacker protocols" are neither verified nor standardised nor safe; publishing them would be a usage guide, which we do not provide on principle. Specific amounts belong in a conversation with a doctor, not in a forum.
As an intranasal 'love' or 'bonding' hormone, oxytocin is promoted in wellness and biohacking circles for more trust, empathy and closeness.
popular, widespread marketing narrative
Not supported by studies: Human evidence for these social/emotional effects after intranasal dosing is mixed and contested in its reproducibility; many early findings did not hold up in larger studies. The popular image runs ahead of the data.
10b
What online communities discuss
Recurring themes from Reddit, Quora and patient forums — synthetically summarised, sources linked. Not scientific evidence, but a signal of what users report. Deliberately separated from the study base.
Non-scientific sources. What users report in forums — synthetically summarised, paraphrased, with link to source. Not validated by studies.
Sorted by discussion frequency · 1 Thema
Discussion frequency: very small base (~8–12 reviews, obstetrics)
On drugs.com, oxytocin is rated low (around 3–5 out of 10 from only about 8–12 reviews). These reviews come almost entirely from the clinical context of labor induction (Pitocin) — an acute hospital use that has little to do with the popular image as a 'cuddle' or 'bonding' hormone.
What this does NOT mean:Review platforms are self-selected, unblinded and not representative; the figures are a snapshot (as of June 2026). They do not replace controlled data — see the studies section. The few reviews reflect only the obstetric use, not the intranasal application promoted in wellness circles.
In the US, injectable oxytocin (e.g. Pitocin) is FDA-approved as a prescription drug for labour induction/augmentation and control of postpartum bleeding. Intranasal use for social/behavioural purposes is not approved and is considered experimental.
2026-06-07
Germany
Prescription
In Germany, oxytocin is available as a prescription medicine (e.g. Syntocinon) for obstetric indications. There is no approval for intranasal use to influence social behaviour or autism; such uses are experimental.
2026-06-07
12
Reconstitution calculator
Pure mg/mL maths — works like a calculator. Not a usage recommendation.
Peptides ship as a dry powder. Once dissolved in a liquid (reconstitution), this calculator answers a single question: how much substance is in one millilitre of solution afterwards?
1Enter the vial's substance amount (printed on the label).
2Enter how much solvent you add.
3Result = concentration in mg per mL.
Printed on the label
/
Liquid you add
=
2.50
mg / mL
5 mg in 2 mL gives 2.50 mg/mL — each millilitre contains 2.50 mg of substance.